A message to those with severe allergies: Suffer no more! | PostIndependent.com

A message to those with severe allergies: Suffer no more!

Scott Rollins
Free Press Health Columnist
Isolated Blowball
Getty Images/iStockphoto | iStockphoto

Are you sick and tired of allergies? Fed up with the eye drops, antihistamines and inhalers? Frustrated with how much you are spending each month trying to manage the symptoms of allergies?

Help is here! Under-the-tongue allergy drops are the easiest and most effective treatment for allergies and it is available now.

Immunotherapy (IT) is recognized as the only curative treatment for allergies. By exposing the immune system to slowly increasing concentrations of an allergen, it will eventually stabilize and regain control of the portion that is hypersensitive to the allergen. The exact mechanisms of how IT works are not fully understood, but they involve shifting a patient’s immune response to an allergen from a predominantly “allergic” T-lymphocyte (TH2) response to a “non-allergic” T-lymphocyte (TH1) response.


IT started in the early 1900s and was based on the idea of the vaccine against infectious agents. Along those lines, the first IT efforts started as injections into the skin, were found to be very effective, and thus remain the standard method of delivery. Even in those early years there was also interest in other routes of administration such as oral, bronchial and nasal, but these methods were never adopted due to cost, mixed success and side effects.

Subcutaneous immunotherapy (SCIT) is the common technique here in the U.S., which requires having to go the doctor’s office for weekly injections — a procedure that is expensive, time-consuming and also dangerous. In 1986, the British Committee for the Safety of Medications reported several deaths caused by SCIT, and raised serious concerns about the safety and the risk/benefit ratio of SCIT. About the same time cheaper and more effective drugs, such as antihistamines and inhaled steroids, were becoming widely available. Amidst this backdrop, the interest in non-injected immunotherapy increased. Sublingual immunotherapy (SLIT) involves taking “allergy drops” under the tongue where the allergens are absorbed in the oral mucosa. This was first tested by randomized controlled trial (RCT) in 1986 and confirmed to be safe and effective. In 1990 the first pediatric study appeared, and since then over 60 double-blind RCTs have confirmed the safety and effectiveness of SLIT.

In recent years several meta-analyses of these studies have appeared in numerous allergy journals, concluding that SLIT is significantly efficacious compared with placebo for rhinitis and asthma in children and adults. In 2003 the respected Cochrane review found that SLIT was safe and effective for treating allergies and the updated 2010 review reinforces the conclusion that SLIT is effective for allergic rhinitis and has been proven to be a safe route of administration.

Just this month we have another favorable review from the Journal of Immunology that concludes “SLIT is confirmed to be a viable alternative to SCIT in the treatment of allergies, with a very favorable safety profile”.

With concern to safety, all clinical trials have consistently agreed that SLIT is safe with most side effects being local and mild. Irritation in the mouth is by far the most common reaction, occurring in as much as 75% of SLIT users. Other side effects included mostly gastrointestinal symptoms, congestion of the eyes or nose, or itching, and occur in 10-20% of users. In over 20 years of use, only six cases of anaphylaxis have been reported with SLIT, and some of these were using non-standardized allergen extracts. In the SLIT comprehensive review, there were no deaths or anaphylaxis events reported.

By comparison, according to the World Allergy Organization, it is estimated that 3.4 fatal and 22.8 near fatal reactions occur every year with SCIT. Local reactions at the injection site, such as redness, swelling and warmth are common with about 10-20% of users experiencing large (>25mm) reactions. Because of the risks, most doctors are not routinely treating children under the age of 12 with SCIT. This is a shame since immunotherapy has been shown to lower the risk of developing asthma.

SLIT is currently commercialized and widely used throughout Europe, Asia, Australia and South America. In a 2006 report, from the Journal of Allergy and Clinical Immunology, the U.S. scientific community finally acknowledged the safety and efficacy of SLIT. The use of SLIT is perfectly legal here in the U.S., but is considered “off-label” by the FDA (like many drugs), and clinical trials for FDA registration in the U.S. are ongoing. Further research is needed to fine-tune issues of effective dosing, treatment schedules, and overall duration of treatment.


The protocol for SLIT is simple. After a medical history and exam, tests for allergies are done, either by a blood test or skin testing. The SLIT drops are then started in a highly diluted form and increased daily until a maintenance dose is achieved. Drops are continued daily, at home, usually for three years. Relief from symptoms is often achieved in the first few months, but it takes 2-3 years for the immune system to reset enough to allow long-lasting relief. If the results are not permanent, most of the time they will last 8-10 years before more treatment is needed.

Our clinical experience with SLIT has been excellent with patients finding allergy relief during the first few months. And given the safety profile, we are comfortable treating children down to age 3, which is just phenomenal given that we are giving relief to these kids while preventing asthma from developing in many of them

SLIT is safe, easy and inexpensive — and it works! We are working with Greer (www.greerlabs.com) and Wellness Pharmacy (www.wellnesshealth.com) to bring SLIT to western Colorado, offering a complete SLIT treatment program at a cost of $100 per month, which includes necessary office visits and the allergy drops. We also offer quick and painless testing for allergies by using the skin-prick or blood draw methods. Put an end to allergies once and for all — call today to get started on the under-the-tongue allergy drops.

Scott Rollins, M.D., is board certified with the American Board of Family Practice and the American Board of Anti-Aging and Regenerative Medicine. He specializes in bioidentical hormone replacement, thyroid and adrenal disorders, fibromyalgia and other complex medical conditions. He is founder and medical director of the Integrative Medicine Center of Western Colorado (www.imcwc.com) and Bellezza Laser Aesthetics (www.bellezzalaser.com). Call 970-245-6911 for appointments or more information.

Support Local Journalism

Support Local Journalism

Readers around Glenwood Springs and Garfield County make the Post Independent’s work possible. Your financial contribution supports our efforts to deliver quality, locally relevant journalism.

Now more than ever, your support is critical to help us keep our community informed about the evolving coronavirus pandemic and the impact it is having locally. Every contribution, however large or small, will make a difference.

Each donation will be used exclusively for the development and creation of increased news coverage.


Start a dialogue, stay on topic and be civil.
If you don't follow the rules, your comment may be deleted.

User Legend: iconModerator iconTrusted User